Accéder au cannabis médical : répondre aux besoins des patients

Le Groupe parlementaire multipartite (APPG) pour la réforme des politiques des drogues conclut une enquête de 7 mois par un appel empathique à légaliser et à réguler le cannabis médical. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

The APPG Report launched on the 13th September emphatically calls on the UK government to legalise medical cannabis based on the results of their 7 month inquiry into the issue and on the findings of an independent review of global evidence commissioned by them that ran alongside the Inquiry.

According to Caroline Lucas MP, co-chair of the All Party Parliamentary Group, ‘Many hundreds of thousands of people in the UK are already taking cannabis for primarily medical reasons. It is totally unacceptable that they should face the added stress of having to break the law to access their medicine. This a matter of compassion and human rights. The government should have the political courage to view the issue of medical cannabis separately from any wider drugs reform and act urgently.’

According to Baroness Molly Meacher, co-chair of the All Party Parliamentary Group, ‘The findings of our inquiry and review of evidence from across the world are clear. Cannabis works as a medicine for a number of medical conditions. The evidence has been strong enough to persuade a growing number of countries and US states to legalise access to medical cannabis. Against this background, the UK scheduling of cannabis as a substance that has no medical value is irrational.’

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.